The chip manufacturing services firm is set to go public $268m in an oversubscribed offering that will enable Samsung, Xiaomi and Intel to exit.

The Softbank, Telstra and American Express-backed e-commerce software producer has closed its IPO after its shares more than tripled in price.

Shell is set to exit the energy storage platform developer in an acquisition by Q Cells, which is already utilising its technology.

Gene therapy developer Freeline Therapeutics priced an upsized offering at the top of its range following $275m in funding from investors including Novo.

UCL's Freeline Therapeutics has priced its shares at $18 to raise nearly $159m through an IPO on the Nasdaq Global Select Market.

Allied Minds claimed a 1.27x investment return after exiting restaurant guest engagement platform TableUp in an all-share transaction.

Humana-backed primary care network Oak Street Health is raising $328m in an offering in which it priced its shares above an expanded range.

NetScientific is poised to acquire EMV Capital in an all-share deal after appointing the latter's managing director as its chief executive in May.

The Telstra, Softbank and American Express-backed e-commerce software provider BigCommerce floated above an expanded range.

Alibaba's financial services spinoff, which counts China Life and China Post as investors, has reportedly set a target for a dual offering that would be the largest in history.